Prednisone

"Prednisone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Descriptor ID	D011241
MeSH Number(s)	D04.210.500.745.432.719.702
Concept/Terms	Prednisone Prednisone Dehydrocortisone delta-Cortisone Rectodelt Rectodelt Prednison Hexal Prednison Hexal Sterapred Sterapred Ultracorten Ultracorten Winpred Winpred Apo-Prednisone Apo-Prednisone Cortan Cortan Cortancyl Cortancyl Panafcort Cutason Cutason Decortin Decortin Dacortin Decortisyl Decortisyl Deltasone Deltasone Encortone Encortone Encorton Enkortolon Enkortolon Kortancyl Kortancyl Liquid Pred Liquid Pred Meticorten Meticorten Orasone Orasone Panasol Panasol Predni Tablinen Predni Tablinen Prednidib Prednidib Predniment Predniment Prednison Acsis Prednison Acsis Acsis, Prednison Pronisone Pronisone Sone Sone Prednison Galen Prednison Galen

Below are MeSH descriptors whose meaning is more general than "Prednisone".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Pregnanes [D04.210.500.745]
Pregnadienes [D04.210.500.745.432]
Pregnadienediols [D04.210.500.745.432.719]
Prednisone [D04.210.500.745.432.719.702]

Below are MeSH descriptors whose meaning is related to "Prednisone".

Below are MeSH descriptors whose meaning is more specific than "Prednisone".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prednisone" by people in this website by year, and whether "Prednisone" was a major or minor topic of these publications.

Bar chart showing 23 publications over 17 distinct years, with a maximum of 4 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1998	0	2	2
2001	0	1	1
2003	0	1	1
2004	0	1	1
2007	1	3	4
2008	1	0	1
2009	0	1	1
2012	0	1	1
2013	0	2	2
2014	0	2	2
2015	0	1	1
2016	0	1	1
2017	0	1	1
2020	0	1	1
2021	0	1	1
2022	0	1	1

Below are the most recent publications written about "Prednisone" by people in Profiles.

Ugarte-Gil MF, Dubey J, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus. Arthritis Care Res (Hoboken). 2023 03; 75(3):585-589.

View in: PubMed
George DJ, Halabi S, Heath EI, Sartor AO, Sonpavde GP, Das D, Bitting RL, Berry W, Healy P, Anand M, Winters C, Riggan C, Kephart J, Wilder R, Shobe K, Rasmussen J, Milowsky MI, Fleming MT, Bearden J, Goodman M, Zhang T, Harrison MR, McNamara M, Zhang D, LaCroix BL, Kittles RA, Patierno BM, Sibley AB, Patierno SR, Owzar K, Hyslop T, Freedman JA, Armstrong AJ. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 08 15; 127(16):2954-2965.

View in: PubMed
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).

View in: PubMed
Alarc?n GS, Ugarte-Gil MF, Pons-Estel G, Vil? LM, Reveille JD, McGwin G. Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort. Lupus. 2019 Mar; 28(3):423-426.

View in: PubMed
Haraoui B, Casado G, Czirj?k L, Taylor A, Bernasconi C, Reiss W, Caporali R. Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies. Clin Exp Rheumatol. 2017 Nov-Dec; 35(6):899-906.

View in: PubMed
Varela-Rosario N, P?rez-Berenguer JL, Vil? LM. Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis. BMJ Case Rep. 2016 Apr 05; 2016.

View in: PubMed
Arroyo-?vila M, Vil? LM. Cardiac tamponade in a patient with mixed connective tissue disease. J Clin Rheumatol. 2015 Jan; 21(1):42-5.

View in: PubMed
Knutson SK, Warholic NM, Johnston LD, Klaus CR, Wigle TJ, Iwanowicz D, Littlefield BA, Porter-Scott M, Smith JJ, Moyer MP, Copeland RA, Pollock RM, Kuntz KW, Raimondi A, Keilhack H. Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas. PLoS One. 2014; 9(12):e111840.

View in: PubMed
Goldman S, Smith L, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Shiramizu B, Barth M, Cairo MS. Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. Br J Haematol. 2014 Nov; 167(3):394-401.

View in: PubMed
Vil?-Rivera K, Jim?nez-Encarnaci?n E, Vil? S. Pulmonary hemorrhage in a patient initially presenting with discoid lupus. P R Health Sci J. 2013 Dec; 32(4):203-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals